Aquarius Population Health

Publications

Download a copy of the Aquarius reference list.

Sign up to receive the latest news and updates by email from Aquarius Population Health.

Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands.

Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.

Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing

Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.

An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain

Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling

The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor

Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland

Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme

Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways

Mapping and comparing COPD Care Pathways across 10 countries to understand barriers to optimal care: clinicians’ perspectives

Further evidence that rapid near-patient testing for chlamydia and gonorrhoea in sexual health clinics benefits patient care

Care Pathway Mapping for Dravet Syndrome (DS) Patients in England

User experience and workflow performance: a pilot evaluation of the Genius Digital Diagnostics System for screening cervical cytology samples

Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting

Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers

Evaluating the benefits and costs of using an mRNA versus DNA HR-HPV assay in the National Cervical Screening Programme in the Netherlands

Modelling the impact of using a DNA compared to mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark

Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada

Evaluating the choice of HPV assay in the French cervical screening programme with a decision tree model

A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK

Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea

Examining the acceptability of offering STI screening in higher educational settings

Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme

Cost analysis of near patient chlamydia and gonorrhoea screening and treatment in further education/technical colleges

Cluster-randomised feasibility trial of a chlamydia test and treat (TnT) service in further education colleges

Modelling cost-effectiveness of multipathogen POC tests for sexually transmitted infections

In vitro diagnostic tests

Three simple tests could save the NHS nearly £6.9 billion

Test n Treat – rapid STI testing and treatment in colleges: study protocol

Enabling more efficient patient management of blood stream infections

Assessing the impact of point-of-care testing for influenza and respiratory syncytial virus in children admitted to hospital

Eradicating HCV

Exploring HCV eradication through diagnosis and treatment strategies

Mapping the treatment pathway for metastatic uveal melanoma patients in England: A qualitative pilot study

Using real world evidence to characterise a cohort of metastatic uveal melanoma patients in England

Quantifying standard of care hospital-related resource utilisation for metastatic uveal melanoma patients in England

Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits

Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment

Evaluating multi-bug point-of-care tests for sexually transmitted infections

Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections

Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections

Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals

Point of Care Testing

Point of care testing: Disruptive innovation – is the NHS ready for it yet?

Modelling the burden of non-muscle-invasive bladder cancer in Europe

How to prevent cervical cancer: HPV – we are coming to get you!

Estimating the clinical impact and costs of implementing a point of care test for influenza A/B and respiratory syncytial virus on an acute paediatric hospital inpatient ward

point-of-care tests paediatrics

A rapid influenza test in hospitals could avoid unnecessary paediatric isolation bed days and save costs

Point of Care Flu Test

Performance of a novel point-of-care molecular assay for the detection of Influenza A, B and RSV in children

Mapping the diagnostic pathway for breast cancer in England and comparison to Europe

Thinking critically about the value and cost of drugs: managing patients with invasive fungal disease

Providing integrated HIV treatment and care for stable patients in general practice

How can European countries improve cervical cancer prevention for women?

Exploring the value of a rapid, on-demand test for the detection of human papillomavirus

Benefits of a point of care test for sexual health testing

Managing Mycoplasma genitalium as an STI

The financial and service implications of splitting fixed-dose antiretroviral drugs – a case study

Point-of-care testing leads the way: article in the Parliamentary Review 2014

Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics

The cost of managing haematology patients with invasive fungal disease

The cost and tariff reimbursement of idiopathic pulmonary fibrosis in England

Treatment for stable HIV patients in England: can we save costs and improve patient care?

The cost-effectiveness of point of care tests for chlamydia and gonorrhoeae in sexual health clinics

Cost effectiveness of screening for Chlamydia trachomatis in Ireland

Costs and cost-effectiveness of different strategies for chlamydia screening and partner notification

What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia?

Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands.

Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.

Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing

Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.

An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain

Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling

The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor

Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland

Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme

Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways

Mapping and comparing COPD Care Pathways across 10 countries to understand barriers to optimal care: clinicians’ perspectives

Further evidence that rapid near-patient testing for chlamydia and gonorrhoea in sexual health clinics benefits patient care

Care Pathway Mapping for Dravet Syndrome (DS) Patients in England

User experience and workflow performance: a pilot evaluation of the Genius Digital Diagnostics System for screening cervical cytology samples

Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting

Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers

Evaluating the benefits and costs of using an mRNA versus DNA HR-HPV assay in the National Cervical Screening Programme in the Netherlands

Modelling the impact of using a DNA compared to mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark

Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada

Evaluating the choice of HPV assay in the French cervical screening programme with a decision tree model

A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK

Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea

Examining the acceptability of offering STI screening in higher educational settings

Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme

Cost analysis of near patient chlamydia and gonorrhoea screening and treatment in further education/technical colleges

Cluster-randomised feasibility trial of a chlamydia test and treat (TnT) service in further education colleges

Modelling cost-effectiveness of multipathogen POC tests for sexually transmitted infections

In vitro diagnostic tests

Three simple tests could save the NHS nearly £6.9 billion

Test n Treat – rapid STI testing and treatment in colleges: study protocol

Enabling more efficient patient management of blood stream infections

Assessing the impact of point-of-care testing for influenza and respiratory syncytial virus in children admitted to hospital

Eradicating HCV

Exploring HCV eradication through diagnosis and treatment strategies

Mapping the treatment pathway for metastatic uveal melanoma patients in England: A qualitative pilot study

Using real world evidence to characterise a cohort of metastatic uveal melanoma patients in England

Quantifying standard of care hospital-related resource utilisation for metastatic uveal melanoma patients in England

Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits

Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment

Evaluating multi-bug point-of-care tests for sexually transmitted infections

Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections

Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections

Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals

Point of Care Testing

Point of care testing: Disruptive innovation – is the NHS ready for it yet?

Modelling the burden of non-muscle-invasive bladder cancer in Europe

How to prevent cervical cancer: HPV – we are coming to get you!

Estimating the clinical impact and costs of implementing a point of care test for influenza A/B and respiratory syncytial virus on an acute paediatric hospital inpatient ward

point-of-care tests paediatrics

A rapid influenza test in hospitals could avoid unnecessary paediatric isolation bed days and save costs

Point of Care Flu Test

Performance of a novel point-of-care molecular assay for the detection of Influenza A, B and RSV in children

Mapping the diagnostic pathway for breast cancer in England and comparison to Europe

Thinking critically about the value and cost of drugs: managing patients with invasive fungal disease

Providing integrated HIV treatment and care for stable patients in general practice

How can European countries improve cervical cancer prevention for women?

Exploring the value of a rapid, on-demand test for the detection of human papillomavirus

Benefits of a point of care test for sexual health testing

Managing Mycoplasma genitalium as an STI

The financial and service implications of splitting fixed-dose antiretroviral drugs – a case study

Point-of-care testing leads the way: article in the Parliamentary Review 2014

Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics

The cost of managing haematology patients with invasive fungal disease

The cost and tariff reimbursement of idiopathic pulmonary fibrosis in England

Treatment for stable HIV patients in England: can we save costs and improve patient care?

The cost-effectiveness of point of care tests for chlamydia and gonorrhoeae in sexual health clinics

Cost effectiveness of screening for Chlamydia trachomatis in Ireland

Costs and cost-effectiveness of different strategies for chlamydia screening and partner notification

What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia?

Sign up to receive the latest news and updates by email from Aquarius Population Health.

For an intro chat about your needs or to receive Aquarius updates